Subscribe To
White gold corp. to participate in upcoming mineral exploration thought leadership panel, metals & mining virtual investor conference, mining investment online emea and the global mining symposium eve
TORONTO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W ) (the "Company") is pleased to announce participation...
February 14, 2022, 4:47 pm
White gold corp. to participate in upcoming mineral exploration thought leadership panel, metals & mining virtual investor conference, mining investment online emea and the global mining symposium eve
TORONTO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W ) (the "Company") is pleased to announce participation...
February 14, 2022, 4:47 pm
White gold corp. to participate in upcoming mineral exploration thought leadership panel, metals & mining virtual investor conference, mining investment online emea and the global mining symposium eve
TORONTO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W ) (the "Company") is pleased to announce participation...
February 14, 2022, 4:47 pm
Watts water technologies announces webcast of its presentation in gabelli funds 32nd annual pump, valve & water systems virtual symposium
NORTH ANDOVER, Mass.--(BUSINESS WIRE)--Watts Water Technologies Announces Webcast of its Presentation in Gabelli Funds 32nd Annual Pump, Valve & Water...
February 14, 2022, 3:26 pm
Watts water technologies announces webcast of its presentation in gabelli funds 32nd annual pump, valve & water systems virtual symposium
NORTH ANDOVER, Mass.--(BUSINESS WIRE)--Watts Water Technologies Announces Webcast of its Presentation in Gabelli Funds 32nd Annual Pump, Valve & Water...
February 14, 2022, 3:26 pm
Watts water technologies announces webcast of its presentation in gabelli funds 32nd annual pump, valve & water systems virtual symposium
NORTH ANDOVER, Mass.--(BUSINESS WIRE)--Watts Water Technologies Announces Webcast of its Presentation in Gabelli Funds 32nd Annual Pump, Valve & Water...
February 14, 2022, 3:26 pm
Orphazyme to present additional data on arimoclomol's mechanism of action during 2022 annual worldsymposium™
Orphazyme A/S Investor News No. 01/2022 www.orphazyme.com Company Registration No. 32266355...
February 7, 2022, 6:22 am
Orphazyme to present additional data on arimoclomol's mechanism of action during 2022 annual worldsymposium™
Orphazyme A/S Investor News No. 01/2022 www.orphazyme.com Company Registration No. 32266355...
February 7, 2022, 6:22 am
Orphazyme to present additional data on arimoclomol's mechanism of action during 2022 annual worldsymposium™
Orphazyme A/S Investor News No. 01/2022 www.orphazyme.com Company Registration No. 32266355...
February 7, 2022, 6:22 am
Sio gene therapies to present at the 18th annual worldsymposium™ 2022
NEW YORK and DURHAM, N.C., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing ...
February 2, 2022, 7:00 am
Sio gene therapies to present at the 18th annual worldsymposium™ 2022
NEW YORK and DURHAM, N.C., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing ...
February 2, 2022, 7:00 am
Sio gene therapies to present at the 18th annual worldsymposium™ 2022
NEW YORK and DURHAM, N.C., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing ...
February 2, 2022, 7:00 am
Panbela: biotech with updated patent protection and unmet market target indication
Data from phase 1b study using SBP-101 for patients with pancreatic cancer will be shown at the American Society of Clinical Oncology Gastrointestinal...
January 5, 2022, 9:27 pm
Panbela: biotech with updated patent protection and unmet market target indication
Data from phase 1b study using SBP-101 for patients with pancreatic cancer will be shown at the American Society of Clinical Oncology Gastrointestinal...
January 5, 2022, 9:27 pm
Panbela: biotech with updated patent protection and unmet market target indication
Data from phase 1b study using SBP-101 for patients with pancreatic cancer will be shown at the American Society of Clinical Oncology Gastrointestinal...
January 5, 2022, 9:27 pm
Novartis' new kisqali data shows consistent overall survival benefit across metastatic breast cancer settings
Novartis AG (NYSE: NVS) shared new data from the MONALEESA Phase 3 program of Kisqali (ribociclib), the CDK4/6 inhibitor in HR+/HER2- metastatic br...
December 8, 2021, 1:27 pm
Novartis' new kisqali data shows consistent overall survival benefit across metastatic breast cancer settings
Novartis AG (NYSE: NVS) shared new data from the MONALEESA Phase 3 program of Kisqali (ribociclib), the CDK4/6 inhibitor in HR+/HER2- metastatic br...
December 8, 2021, 1:27 pm
Novartis' new kisqali data shows consistent overall survival benefit across metastatic breast cancer settings
Novartis AG (NYSE: NVS) shared new data from the MONALEESA Phase 3 program of Kisqali (ribociclib), the CDK4/6 inhibitor in HR+/HER2- metastatic br...
December 8, 2021, 1:27 pm